The US Food and Drug Administration (FDA) has unveiled its comprehensive final guidance for industry on collecting crucial post-marketing safety…
Read More
Cellular Intelligence Licenses Novo Nordisk’s Parkinson’s Cell Therapy Program Following Company’s Strategic Pivot
Seven months after Danish pharmaceutical giant Novo Nordisk officially shuttered its dedicated cell therapy unit in October 2025, a significant…
Read More
Ginkgo Bioworks CEO Jason Kelly Discusses Autonomous Labs and the Future of Biopharma R&D
The landscape of biopharmaceutical research and development (R&D) is undergoing a seismic shift, driven by the integration of advanced robotics…
Read More
The Evolving Role of Vitamin E TPGS in Advanced Parenteral Drug Delivery
For decades, d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS), a derivative of vitamin E, has been a cornerstone in oral drug…
Read More
Pharma 50: Keytruda holds the top brand slot, but tirzepatide and semaglutide have already passed it at the molecule level in FY2025
Merck’s immunotherapy blockbuster, Keytruda (pembrolizumab), maintained its dominant position as the pharmaceutical industry’s leading brand in Fiscal Year 2025, recording…
Read More
Angelini Pharma Acquires Catalyst Pharmaceuticals for $4.1 Billion to Bolster Rare Disease and Brain Health Portfolio
Angelini Pharma, a prominent player in the pharmaceutical sector, has announced a definitive agreement to acquire Catalyst Pharmaceuticals for an…
Read More
Pharma 50: The 50 best-selling drugs of FY2025
The pharmaceutical landscape of Fiscal Year 2025 witnessed a dynamic reshuffling at its apex, with Merck’s Keytruda steadfastly holding its…
Read More
Paradigm Health eSource Casebook Revolutionizes Clinical Trial Data Management, Addressing Industry-Wide Challenges
The landscape of clinical trials is undergoing a significant transformation, driven by increasingly complex protocols and the escalating demands placed…
Read More
Novartis Breaks Ground on New Radioligand Therapy Manufacturing Facility in Denton, Texas, Bolstering US Healthcare Infrastructure
Novartis has commenced construction on a significant new radioligand therapy (RLT) manufacturing facility in Denton, Texas, a pivotal development in…
Read More
The Autonomous Revolution: How Ginkgo Bioworks is Driving a Paradigm Shift in Biopharma R&D
The biopharmaceutical industry, long reliant on the meticulous, hands-on work of human researchers, is on the cusp of a profound…
Read MoreYOU MAY HAVE MISSED
